Candid Health获1.2亿美元融资用于AI RCM平台
Candid Health Snags $120M for AI RCM Platform
Candid Health，一个收入周期管理平台，周三宣布其在D轮融资中筹集了1.2亿美元。
总部位于旧金山的Candid Health服务于医疗团体、管理服务组织和数字健康公司。其AI驱动系统自动化医疗计费和健康保险理赔，帮助医疗提供者更准确、更快速地获得付款。它支持200多家医疗机构，包括Talkiatry、Tia、Luna、Cortica和Nourish。
Candid Health联合创始人兼首席执行官Nick Perry在一份声明中表示：“Candid为美国许多最重要、最具创新性的医疗机构提供金融基础设施支持。传统参与者未能跟上步伐，而那些在原有系统上轻撒AI的公司尚未交付成果。过去七年里，我们从零开始重建了这一领域核心基础设施。”由以下机构呈现赞助文章2026年全球员工队伍中七大现代AI驱动EAP提供商发现2026年顶级AI驱动EAP提供商。比较Kyan Health和Spring Health等平台在分诊速度、全球覆盖范围和临床质量方面的表现，以转变员工福祉。
作者：Tiffany Cabasso，Kyan Health运营总监 | 心理学家，FSP D轮融资由Sixth Street Growth领投，Oak HC/FT、8VC和Y Combinator参投。此前，2025年2月由Oak HC/FT领投的C轮融资为5250万美元。总体而言，Candid Health已筹集约2.19亿美元。
据Sixth Street Growth称，Candid Health正在填补收入周期管理领域一个未被满足的需求。
Sixth Street Growth董事总经理Alex Katz告诉MedCity News：“Candid正凭借现代AI驱动的基础设施，解决医疗收入周期管理中的重大结构性挑战，为整个系统带来显著效率提升。我们相信，Candid的平台有望长期成为未来医疗RCM的基础设施。在尽职调查中，我们听到了客户对Candid团队高度专注于交付成果的卓越反馈，我们期待携手他们开启下一增长篇章。”Candid Health表示，这笔资金将支持对自动化的持续投资，加速代理式RCM解决方案的开发，并扩充团队。
由以下机构呈现赞助文章缩小职场心理健康中质量与可负担性之间的差距在一次采访中，Kyan Health联合创始人兼首席商务官Konstantin Struck讨论了Kyan如何以可负担的价格，让中型市场和企业雇主获得优质的员工心理健康服务。
作者：Stephanie Baum
该公告发布之际，每年约有2800亿美元用于医疗收入周期管理。公司表示，Candid Health希望降低这些成本。
Candid Health联合创始人兼首席运营官Doug Proctor告诉MedCity News：“美国医疗过于昂贵，且难以为继。我们希望减少美国医疗中后端低效和浪费。我们希望让医疗提供者能够将更多时间投入到患者护理上。”Candid Health并非唯一一家AI RCM公司。其他公司包括AKASA、RapidClaims和Nym Health。
图片来源：Andriy Onufriyenko，Getty Images
Candid Health, a revenue cycle management platform, announced Wednesday that it raised $120 million in Series D funding.
San Francisco-based Candid Health serves medical groups, managed service organizations and digital health companies. Its AI-powered system automates medical billing and health insurance claims to help providers get paid more accurately and quickly. It supports more than 200 healthcare organizations, including Talkiatry, Tia, Luna, Cortica and Nourish.
“Candid powers the financial infrastructure for many of the most important and innovative healthcare organizations in the United States,” said Nick Perry, Candid Health co-founder and CEO, in a statement. “The legacy players haven’t kept pace, and the companies lightly sprinkling AI on top of them have yet to deliver. We’ve spent the past seven years rebuilding the core infrastructure of this problem space from the ground up.” The Series D round was led by Sixth Street Growth, with participation from Oak HC/FT, 8VC and Y Combinator. This comes after a $52.5 million Series C raise in February 2025 led by Oak HC/FT. In total, Candid Health has raised about $219 million.
According to Sixth Street Growth, Candid Health is filling an unmet need in the revenue cycle management space.
“Candid is solving major structural challenges in healthcare revenue cycle management with modern, AI-powered infrastructure that drives meaningful efficiency across the system, and we believe Candid’s platform is well-positioned to become the foundational infrastructure for the future of healthcare RCM over the long term. In our diligence, we heard exceptional feedback from customers about the Candid team’s deep focus on delivering results, and we’re excited to partner with them for their next chapter of growth,” Alex Katz, managing director at Sixth Street Growth, told MedCity News.
The funding will support continued investment in automation, accelerate development of agentic RCM solutions and grow its team, Candid Health said.
The announcement comes at a time when about $280 billion is spent annually on healthcare revenue cycle management. Candid Health hopes to bring down these costs, the company said.
“American healthcare is too expensive, and it’s untenable. We want to reduce the amount of back-end inefficiency and waste in American healthcare. We want to empower providers to spend more time focusing on patient care,” Doug Proctor, co-founder and COO of Candid Health, told MedCity News.
Candid Health isn’t the only AI RCM company out there. Others include AKASA, RapidClaims and Nym Health.
Photo: Andriy Onufriyenko, Getty Images